Skip to main content

Published locations for Biogen plans to submit application to FDA for Alzheimer’s drug aducanumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Biogen plans to submit application to FDA for Alzheimer’s drug aducanumab

User login

  • Reset your password
  • /content/biogen-plans-submit-application-fda-alzheimers-drug-aducanumab
  • /clinicianreviews/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers
  • /familypracticenews/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda
  • /internalmedicinenews/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda
  • /neurologyreviews/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers
  • /jcomjournal/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers-drug
  • /psychiatry/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers-drug
  • /internalmedicine/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers
  • /neurology/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers-drug
  • /familymedicine/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda-alzheimers
  • /clinicalneurologynews/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda
  • /clinicalpsychiatrynews/article/210636/alzheimers-cognition/biogen-plans-submit-application-fda